Sens. Wyden, Warren Urges GAO to Review States Medicaid Coverage of Mifepristone in Aftermath of Dobbs Decision
July 03, 2024
July 03, 2024
WASHINGTON, July 3 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release:
Senate Finance Committee Chair Ron Wyden, D-Ore., and Senator Elizabeth Warren, D-Mass., wrote a letter to the Government Accountability Office (GAO) urging the agency to update its 2019 report on state Medicaid programs' coverage of mifepristone, which, in addition to misoprostol, is the only Food and Drug Administration (FDA)-approved prescription for aborti . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., and Senator Elizabeth Warren, D-Mass., wrote a letter to the Government Accountability Office (GAO) urging the agency to update its 2019 report on state Medicaid programs' coverage of mifepristone, which, in addition to misoprostol, is the only Food and Drug Administration (FDA)-approved prescription for aborti . . .